annual FCF:
$4.03B+$2.93B(+265.32%)Summary
- As of today (September 17, 2025), TAK annual free cash flow is $4.03 billion, with the most recent change of +$2.93 billion (+265.32%) on March 1, 2025.
- During the last 3 years, TAK annual FCF has fallen by -$3.40 billion (-45.75%).
- TAK annual FCF is now -45.75% below its all-time high of $7.43 billion, reached on March 31, 2022.
Performance
TAK Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$891.15M+$270.38M(+43.56%)Summary
- As of today (September 17, 2025), TAK quarterly free cash flow is $891.15 million, with the most recent change of +$270.38 million (+43.56%) on June 1, 2025.
- Over the past year, TAK quarterly FCF has increased by +$752.68 million (+543.58%).
- TAK quarterly FCF is now -66.37% below its all-time high of $2.65 billion, reached on March 31, 2022.
Performance
TAK quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$4.77B+$752.68M(+18.72%)Summary
- As of today (September 17, 2025), TAK TTM free cash flow is $4.77 billion, with the most recent change of +$752.68 million (+18.72%) on June 1, 2025.
- Over the past year, TAK TTM FCF has increased by +$2.12 billion (+79.96%).
- TAK TTM FCF is now -36.00% below its all-time high of $7.46 billion, reached on March 31, 2022.
Performance
TAK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
TAK Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +265.3% | +543.6% | +80.0% |
| 3 y3 years | -45.8% | +418.8% | -23.6% |
| 5 y5 years | +29.8% | +26.6% | +42.8% |
TAK Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -45.8% | +265.3% | -57.9% | +163.1% | -23.6% | +413.8% |
| 5 y | 5-year | -45.8% | +265.3% | -66.4% | +163.1% | -36.0% | +413.8% |
| alltime | all time | -45.8% | +930.4% | -66.4% | +163.1% | -36.0% | +413.8% |
TAK Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $891.15M(+43.6%) | $4.77B(+18.7%) |
| Mar 2025 | $4.03B(+265.3%) | $620.77M(-68.7%) | $4.02B(-16.9%) |
| Dec 2024 | - | $1.98B(+55.4%) | $4.84B(+52.6%) |
| Sep 2024 | - | $1.28B(+822.2%) | $3.17B(+19.5%) |
| Jun 2024 | - | $138.47M(-90.4%) | $2.65B(+140.7%) |
| Mar 2024 | $1.10B(-38.6%) | $1.44B(+352.4%) | $1.10B(-172.5%) |
| Dec 2023 | - | $317.45M(-58.3%) | -$1.52B(-643.0%) |
| Sep 2023 | - | $760.36M(-153.9%) | $280.11M(-58.4%) |
| Jun 2023 | - | -$1.41B(+18.9%) | $672.76M(-62.7%) |
| Mar 2023 | $1.80B(-75.8%) | -$1.19B(-156.0%) | $1.81B(-68.0%) |
| Dec 2022 | - | $2.12B(+83.7%) | $5.64B(-4.9%) |
| Sep 2022 | - | $1.15B(-512.4%) | $5.93B(-5.1%) |
| Jun 2022 | - | -$279.56M(-110.6%) | $6.25B(-16.2%) |
| Mar 2022 | $7.43B(+17.9%) | $2.65B(+10.1%) | $7.46B(+1.0%) |
| Dec 2021 | - | $2.41B(+63.6%) | $7.38B(+17.3%) |
| Sep 2021 | - | $1.47B(+58.0%) | $6.29B(-4.5%) |
| Jun 2021 | - | $930.87M(-63.8%) | $6.59B(+3.6%) |
| Mar 2021 | $6.30B(+103.0%) | $2.57B(+95.2%) | $6.36B(+35.2%) |
| Dec 2020 | - | $1.32B(-25.5%) | $4.71B(+30.8%) |
| Sep 2020 | - | $1.77B(+151.3%) | $3.60B(+7.7%) |
| Jun 2020 | - | $703.66M(-23.3%) | $3.34B(+8.2%) |
| Mar 2020 | $3.11B(+104.4%) | $917.63M(+336.9%) | $3.09B(+17.6%) |
| Dec 2019 | - | $210.06M(-86.1%) | $2.63B(-11.2%) |
| Sep 2019 | - | $1.51B(+236.6%) | $2.96B(+53.6%) |
| Jun 2019 | - | $449.18M(-1.3%) | $1.93B(+26.8%) |
| Mar 2019 | $1.52B(-33.0%) | $455.08M(-16.1%) | $1.52B(-22.5%) |
| Dec 2018 | - | $542.38M(+13.1%) | $1.96B(-1.5%) |
| Sep 2018 | - | $479.71M(+1030.5%) | $1.99B(+8.7%) |
| Jun 2018 | - | $42.43M(-95.3%) | $1.83B(-18.8%) |
| Mar 2018 | $2.27B(+65.9%) | $895.15M(+56.4%) | $2.25B(+7.3%) |
| Dec 2017 | - | $572.38M(+78.5%) | $2.10B(+47.1%) |
| Sep 2017 | - | $320.70M(-31.1%) | $1.43B(-2.9%) |
| Jun 2017 | - | $465.27M(-37.4%) | $1.47B(+8.8%) |
| Mar 2017 | $1.37B(-381.6%) | $742.74M(-841.9%) | $1.35B(-270.1%) |
| Dec 2016 | - | -$100.12M(-127.6%) | -$794.54M(+238.8%) |
| Sep 2016 | - | $363.13M(+4.9%) | -$234.54M(+31.4%) |
| Jun 2016 | - | $346.02M(-124.7%) | -$178.54M(-63.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | -$485.53M(-171.4%) | -$1.40B(-405.2%) | -$486.41M(-150.1%) |
| Dec 2015 | - | $459.88M(+9.7%) | $971.01M(+10.2%) |
| Sep 2015 | - | $419.12M(+998.4%) | $881.41M(-9.4%) |
| Jun 2015 | - | $38.16M(-29.1%) | $973.27M(+43.9%) |
| Mar 2015 | $680.19M(-2.4%) | $53.84M(-85.5%) | $676.25M(+8.7%) |
| Dec 2014 | - | $370.28M(-27.5%) | $622.41M(+146.9%) |
| Sep 2014 | - | $510.98M(-297.4%) | $252.12M(-197.4%) |
| Jun 2014 | - | -$258.86M(-120.6%) | -$258.86M(-110.8%) |
| Mar 2014 | $696.96M(-73.8%) | - | - |
| Mar 2013 | $2.66B(-23.6%) | - | - |
| Mar 2012 | $3.48B(+46.9%) | - | - |
| Mar 2011 | $2.37B(-25.3%) | $1.26B(+213.7%) | $2.39B(+18.9%) |
| Dec 2010 | - | $401.53M(-51.7%) | $2.01B(-9.5%) |
| Sep 2010 | - | $831.19M(-908.1%) | $2.22B(-7.2%) |
| Jun 2010 | - | -$102.85M(-111.7%) | $2.39B(-25.1%) |
| Mar 2010 | $3.17B(+11.1%) | $880.34M(+44.0%) | $3.19B(+38.1%) |
| Dec 2009 | - | $611.41M(-39.0%) | $2.31B(+36.0%) |
| Sep 2009 | - | $1.00B(+43.8%) | $1.70B(+143.8%) |
| Jun 2009 | - | $697.11M | $697.11M |
| Mar 2009 | $2.85B(+25.4%) | - | - |
| Mar 2008 | $2.27B(+47.6%) | - | - |
| Mar 2007 | $1.54B(-48.9%) | - | - |
| Mar 2006 | $3.02B(+34.1%) | - | - |
| Mar 2005 | $2.25B(-1.0%) | - | - |
| Mar 2004 | $2.27B(+20.5%) | - | - |
| Mar 2003 | $1.89B(+16.1%) | - | - |
| Mar 2002 | $1.63B(-3.2%) | - | - |
| Mar 2001 | $1.68B(+51.4%) | - | - |
| Mar 2000 | $1.11B(+85.4%) | - | - |
| Mar 1999 | $598.49M(-2.1%) | - | - |
| Mar 1998 | $611.51M(+10.8%) | - | - |
| Mar 1997 | $552.09M(-3.6%) | - | - |
| Mar 1996 | $572.50M(+65.0%) | - | - |
| Mar 1995 | $347.07M(-39.1%) | - | - |
| Mar 1994 | $569.52M(+232.2%) | - | - |
| Mar 1993 | $171.46M(-44.8%) | - | - |
| Mar 1992 | $310.79M(+961.7%) | - | - |
| Mar 1991 | $29.27M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual free cash flow?
- What is the all time high annual FCF for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual FCF year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly free cash flow?
- What is the all time high quarterly FCF for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly FCF year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM free cash flow?
- What is the all time high TTM FCF for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM FCF year-on-year change?
What is Takeda Pharmaceutical Company Limited annual free cash flow?
The current annual FCF of TAK is $4.03B
What is the all time high annual FCF for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual free cash flow is $7.43B
What is Takeda Pharmaceutical Company Limited annual FCF year-on-year change?
Over the past year, TAK annual free cash flow has changed by +$2.93B (+265.32%)
What is Takeda Pharmaceutical Company Limited quarterly free cash flow?
The current quarterly FCF of TAK is $891.15M
What is the all time high quarterly FCF for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly free cash flow is $2.65B
What is Takeda Pharmaceutical Company Limited quarterly FCF year-on-year change?
Over the past year, TAK quarterly free cash flow has changed by +$752.68M (+543.58%)
What is Takeda Pharmaceutical Company Limited TTM free cash flow?
The current TTM FCF of TAK is $4.77B
What is the all time high TTM FCF for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM free cash flow is $7.46B
What is Takeda Pharmaceutical Company Limited TTM FCF year-on-year change?
Over the past year, TAK TTM free cash flow has changed by +$2.12B (+79.96%)